Christopher R. Fenimore - 11 Dec 2021 Form 4 Insider Report for REGENERON PHARMACEUTICALS, INC. (REGN)

Role
SVP Controller
Signature
/s/** Christopher R. Fenimore
Issuer symbol
REGN
Transactions as of
11 Dec 2021
Net transactions value
-$179,372
Form type
4
Filing time
14 Dec 2021, 15:10:29 UTC
Previous filing
10 Dec 2021
Next filing
01 Apr 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction REGN Common Stock Tax liability $179,372 -270 -1.3% $664.34 21,122 11 Dec 2021 Direct
holding REGN Common Stock 2,082 11 Dec 2021 2021 GRAT
holding REGN Common Stock 1,459 11 Dec 2021 By 401(k) Plan
holding REGN Common Stock 1,897 11 Dec 2021 By Trust F1
holding REGN Common Stock 1,348 11 Dec 2021 by 2018 GRAT
holding REGN Common Stock 25 11 Dec 2021 by Trust for Daugh
holding REGN Common Stock 25 11 Dec 2021 by Trust for Son
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares are held in a trust for the benefit of the reporting person's spouse. The reporting person and the reporting person's spouse are trustees of the trust.